HR18034

DRUG5 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.

Conditions

Inguinal Hernia RepairPostoperative Pain Management in Total Knee ArthroplastyPostsurgical Pain ManagementThoracoscopic Lobectomy

Phase 1

A Trial of HR18034 in Inguinal Hernia Repair

Jiangsu HengRui Medicine Co., Ltd.Inguinal Hernia Repair

Start: 2020-10-01End: 2021-05-30Target: 64Updated: 2020-09-16

Phase 2

A Trial of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy.

CompletedNCT05376904

Shanghai Hengrui Pharmaceutical Co., Ltd.Postsurgical Pain Management

Start: 2022-06-13End: 2022-10-05Updated: 2023-03-20

Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management

Shanghai Hengrui Pharmaceutical Co., Ltd.Thoracoscopic Lobectomy

Start: 2023-02-21End: 2023-06-30Target: 96Updated: 2023-03-15

Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management in TKA

TerminatedNCT06509958

Shanghai Hengrui Pharmaceutical Co., Ltd.Postoperative Pain Management in Total Knee Arthroplasty

Start: 2024-08-20End: 2024-10-10Updated: 2024-10-30

Phase 3

A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy

CompletedNCT05769855

Shanghai Hengrui Pharmaceutical Co., Ltd.Postsurgical Pain Management

Start: 2023-03-21End: 2023-10-30Updated: 2024-03-07